miltefosine has been researched along with Antibody Deficiency Syndrome in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Miltefosine is an option for treating Old World leishmaniasis (Leishmania infantum) and immunodeficiency should be considered in patients with recurrent leishmaniasis." | 1.39 | Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome. ( Arnold, A; Blum, J; Holbro, A; Neumayr, A; Stoeckle, M; Weisser, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stoeckle, M | 1 |
| Holbro, A | 1 |
| Arnold, A | 1 |
| Neumayr, A | 1 |
| Weisser, M | 1 |
| Blum, J | 1 |
1 other study available for miltefosine and Antibody Deficiency Syndrome
| Article | Year |
|---|---|
Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome.
Topics: Administration, Oral; Aged; Antiprotozoal Agents; Histocytochemistry; Humans; Immunocompromised Host | 2013 |